Stephens Inc. AR Raises Stock Holdings in The Clorox Company $CLX

Stephens Inc. AR increased its position in The Clorox Company (NYSE:CLX) by 32.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,778 shares of the company’s stock after acquiring an additional 924 shares during the period. Stephens Inc. AR’s holdings in Clorox were worth $454,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. American National Bank & Trust raised its stake in shares of Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after buying an additional 89 shares during the last quarter. Ransom Advisory Ltd purchased a new position in shares of Clorox during the 1st quarter valued at about $35,000. GW&K Investment Management LLC raised its stake in shares of Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after buying an additional 208 shares during the last quarter. Roble Belko & Company Inc raised its stake in shares of Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock valued at $53,000 after buying an additional 211 shares during the last quarter. Finally, IMA Advisory Services Inc. purchased a new position in shares of Clorox during the 1st quarter valued at about $58,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Clorox Stock Down 0.3%

CLX stock opened at $116.02 on Friday. The firm has a market cap of $14.13 billion, a PE ratio of 17.79, a PEG ratio of 0.96 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The firm’s 50 day moving average price is $121.18 and its 200-day moving average price is $126.94. The Clorox Company has a one year low of $115.83 and a one year high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.3%. Clorox’s dividend payout ratio is currently 76.07%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CLX. Barclays cut their price target on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, September 30th. Morgan Stanley cut their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research note on Friday, August 1st. Citigroup cut their price target on Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. JPMorgan Chase & Co. cut their price target on Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a research note on Friday, October 10th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, Clorox has an average rating of “Reduce” and a consensus price target of $130.20.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.